Sertraline-induced ventricular tachycardia

Nishit H. Patel, Harsh Golwala, Stavros Stavrakis, Eliot Schechter

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Sertraline is a selective serotonin reuptake inhibitor, which is a commonly used drug for major depressive disorder. Most frequently reported adverse effects of sertraline in patients receiving 50-150 mg/d are dry mouth, headache, diarrhea, nausea, vomiting, sweating, and dizziness. We hereby report one of the few cases of sertraline-induced ventricular tachycardia, which has been for the first time objectively assessed by the Naranjo scale. We therefore urge the primary care physicians and the cardiologists to keep sertraline as a possible precipitating factor for evaluation of ventricular tachycardia.

Original languageEnglish (US)
Pages (from-to)e720-e722
JournalAmerican Journal of Therapeutics
Volume20
Issue number6
DOIs
StatePublished - Jan 1 2013
Externally publishedYes

Fingerprint

Sertraline
Ventricular Tachycardia
Precipitating Factors
Sweating
Major Depressive Disorder
Serotonin Uptake Inhibitors
Primary Care Physicians
Dizziness
Nausea
Vomiting
Headache
Mouth
Diarrhea
Pharmaceutical Preparations

Keywords

  • Naranjo scale
  • Sertraline
  • Ventricular tachycardia

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)

Cite this

Sertraline-induced ventricular tachycardia. / Patel, Nishit H.; Golwala, Harsh; Stavrakis, Stavros; Schechter, Eliot.

In: American Journal of Therapeutics, Vol. 20, No. 6, 01.01.2013, p. e720-e722.

Research output: Contribution to journalArticle

Patel, Nishit H. ; Golwala, Harsh ; Stavrakis, Stavros ; Schechter, Eliot. / Sertraline-induced ventricular tachycardia. In: American Journal of Therapeutics. 2013 ; Vol. 20, No. 6. pp. e720-e722.
@article{98b1335fba6f4f528c33653b43394259,
title = "Sertraline-induced ventricular tachycardia",
abstract = "Sertraline is a selective serotonin reuptake inhibitor, which is a commonly used drug for major depressive disorder. Most frequently reported adverse effects of sertraline in patients receiving 50-150 mg/d are dry mouth, headache, diarrhea, nausea, vomiting, sweating, and dizziness. We hereby report one of the few cases of sertraline-induced ventricular tachycardia, which has been for the first time objectively assessed by the Naranjo scale. We therefore urge the primary care physicians and the cardiologists to keep sertraline as a possible precipitating factor for evaluation of ventricular tachycardia.",
keywords = "Naranjo scale, Sertraline, Ventricular tachycardia",
author = "Patel, {Nishit H.} and Harsh Golwala and Stavros Stavrakis and Eliot Schechter",
year = "2013",
month = "1",
day = "1",
doi = "10.1097/MJT.0b013e3182192d6e",
language = "English (US)",
volume = "20",
pages = "e720--e722",
journal = "American Journal of Therapeutics",
issn = "1075-2765",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Sertraline-induced ventricular tachycardia

AU - Patel, Nishit H.

AU - Golwala, Harsh

AU - Stavrakis, Stavros

AU - Schechter, Eliot

PY - 2013/1/1

Y1 - 2013/1/1

N2 - Sertraline is a selective serotonin reuptake inhibitor, which is a commonly used drug for major depressive disorder. Most frequently reported adverse effects of sertraline in patients receiving 50-150 mg/d are dry mouth, headache, diarrhea, nausea, vomiting, sweating, and dizziness. We hereby report one of the few cases of sertraline-induced ventricular tachycardia, which has been for the first time objectively assessed by the Naranjo scale. We therefore urge the primary care physicians and the cardiologists to keep sertraline as a possible precipitating factor for evaluation of ventricular tachycardia.

AB - Sertraline is a selective serotonin reuptake inhibitor, which is a commonly used drug for major depressive disorder. Most frequently reported adverse effects of sertraline in patients receiving 50-150 mg/d are dry mouth, headache, diarrhea, nausea, vomiting, sweating, and dizziness. We hereby report one of the few cases of sertraline-induced ventricular tachycardia, which has been for the first time objectively assessed by the Naranjo scale. We therefore urge the primary care physicians and the cardiologists to keep sertraline as a possible precipitating factor for evaluation of ventricular tachycardia.

KW - Naranjo scale

KW - Sertraline

KW - Ventricular tachycardia

UR - http://www.scopus.com/inward/record.url?scp=84895098450&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84895098450&partnerID=8YFLogxK

U2 - 10.1097/MJT.0b013e3182192d6e

DO - 10.1097/MJT.0b013e3182192d6e

M3 - Article

VL - 20

SP - e720-e722

JO - American Journal of Therapeutics

JF - American Journal of Therapeutics

SN - 1075-2765

IS - 6

ER -